BLLN
BillionToOne, Inc.
NASDAQ · Healthcare · Medical - Diagnostics & Research · US
$102.92
+1.87%Price chart
Sep 21Sep 24Sep 29Oct 2Oct 7Oct 12Oct 15Oct 20
Key dataOct 20, 2026
Open$101.12
From 52W high−31.37%
Volume49277.00
Market cap$4.86B
P/E (TTM)149.1x
P/S (TTM)12.2x
Div yield—
Key dataOct 20, 2026
Open
$101.12
From 52W high
−31.37%
Volume
49277.00
Market cap
$4.86B
ValuationView details →
P/E (Fwd)
120.8x
EV/EBITDA
88.6x
P/E (TTM)
149.1x
RSI (14)
48.0
MomentumView details →
1D Return
+1.87%
YTD Return
+23.24%
Similar companies
Latest newsMore news →
BillionToOne, Inc. announced that it plans to release financial results for the third quarter ended September 30, 2026, after market close on November 4, 2026, and hold a conference call that day.6d agoBillionToOne launched Northstar Origin, a new liquid biopsy add-on test for tissue-of-origin prediction, and expanded its Northstar Select panel from 84 to 102 genes.49d ago